TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|---|---|---|---|---|---|---|---|---|---|---|
| S | %ret | 1 | 1 | 3 | 3 | 5 | 5 | 43 | 138 | 247 | 74 |
| S | %wins | 33 | 33 | 67 | 0 | 0 | 0 | 22 |
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1/7/25 20:00 | 1/3/25 | ANTX | An2 Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Chanda Sanjay | CA | O | Chief De | S | -4 | 1.34 | 0 | -3 | -9 | 30 | D | ||||||||||||||
3/4/15 19:22 | 3/4/15 | ANAC | Anacor Pharmaceuticals, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Chanda Sanjay | CA | O | SVP,Drug | S.d | -225 | 45.00 | 16 | -5 | -15 | 29 | D | 999 | 120 | 90 | 28 | 29 | 14 | 2 | 0 | 3 | 9 | 26 | 53 | 191 | 42 |
12/1/14 19:50 | 11/26/14 | ANAC | Anacor Pharmaceuticals, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Chanda Sanjay | CA | O | SVP,Drug | S.d | -175 | 35.00 | 14 | -5 | -56 | 4 | D | 543 | 160 | 144 | 48 | 34 | 21 | 11 | 6 | 5 | 7 | -6 | 32 | 103 | 242 |
9/12/14 16:08 | 9/10/14 | ANAC | Anacor Pharmaceuticals, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Chanda Sanjay | CA | O | SVP,Drug | S.d | -243 | 24.25 | 13 | -10 | -71 | 4 | D | 281 | 138 | 26 | 58 | 53 | 26 | 9 | 14 | 0 | 0 | -5 | 43 | 121 | 457 |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |